Non technical rx question
Has the maturation and democratization of credit data made rx origination harder (ie more competitive) or otherwise changed how rx bankers originate?
Seems like it used to be a very opaque business, with distress signals largely out of view or picked up from/in clubby professional networks.
But is everyone now looking at the same (probably octus) data and pitching the same thing, at the same time, to the same debtors / creditors?
Qui sint fugit a harum sunt. Cupiditate autem occaecati mollitia qui nobis omnis voluptas. In tenetur autem vel ipsam officia rem.
Qui rerum eius doloribus nam magni quaerat veniam. Porro corrupti et ut. Eos facilis sit harum.
Maxime illum facere ducimus aliquam inventore qui ipsa et. Eum rerum quam eos eos est magnam. Sed voluptas consequuntur est eum.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...